dacarbazine and Recrudescence

dacarbazine has been researched along with Recrudescence in 146 studies

Research

Studies (146)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (3.42)	18.7374
1990's	23 (15.75)	18.2507
2000's	48 (32.88)	29.6817
2010's	65 (44.52)	24.3611
2020's	5 (3.42)	2.80

Authors

Authors	Studies
Borsi, E; Ionita, I; Pescaru, M; Potre, C; Potre, O; Samfireag, M; Sima, A; Tudor, R	1
Andre, M; Aurer, I; Barrington, SF; Clifton-Hadley, L; Counsell, N; Federico, M; Fiaccadori, V; Fortpied, C; Illidge, T; Neven, A; Phillips, EH; Radford, J; Raemaekers, JMM	1
Adouni, O; Bertucci, F; Birnbaum, D; Finetti, P; Gamoudi, A; Manai, M; Mezlini, A; Zawati, I	1
Baues, C; Behringer, K; Borchmann, P; Bröckelmann, PJ; Engert, A; Fuchs, M; Guhl, T; Moccia, AA; Müller, H; Pabst, T; Rank, A; Soekler, M; Vieler, T; von Tresckow, B	1
Baues, C; Borchmann, P; Celik, E; Eich, H; Engert, A; Fuchs, M; Goergen, H; Kobe, C; Marnitz, S; Rosenbrock, J; Voltin, CA	1
Baines, SJ; Blackwood, L; Elliott, JW; Treggiari, E	1
Abou Yehia, Z; Akhtari, M; Chuang, H; Dabaja, BS; Dong, W; Fanale, M; Fayad, LE; Garg, N; Gunther, JR; Hagemeister, FB; Lee, HJ; Mawlawi, O; Milgrom, SA; Oki, Y; Osborne, EM; Pinnix, CC; Reddy, JP; Rohren, E; Smith, GL	1
Champlin, R; Cortes, J; Estrov, Z; Garcia-Manero, G; Garris, R; Huang, X; Jabbour, E; Jacob, J; Jain, N; Kadia, T; Kantarjian, H; Kebriaei, P; Khouri, MR; Konopleva, M; Marin, D; O'Brien, S; Patel, Y; Ravandi, F; Rytting, M; Sasaki, K; Short, NJ; Takahashi, K; Thomas, D	1
Bartlett, NL	2
Cheson, B; Narkhede, M; Sarraf Yazdy, M	1
Ahern, C; Ames, MM; Blaney, SM; Fouladi, M; Gilbertson, RJ; Horton, T; Hummel, TR; Ingle, AM; McGovern, RM; Reid, JM; Wagner, L; Weigel, B	1
Davidson, TB; Malogolowkin, M; Mascarenhas, L; May, W; Sposto, R; Venkatramani, R	1
Baumann, C; Beauchesne, P; Blonski, M; Chauffert, B; Darlix, A; Ghiringhelli, F; Lorgis, V; Pinelli, C; Rech, F; Taillandier, L; Zouaoui, S	1
Amoroso, D; Andreuccetti, M; Falcone, A; Fontana, A; Galli, C; Galli, L; Landi, L; Lombardi, G; Porta, C; Zagonel, V; Zustovich, F	1
Broholm, H; Christensen, IJ; Grunnet, K; Kosteljanetz, M; Michaelsen, SR; Poulsen, HS; Stockhausen, MT	1
Aerts, I; Amoroso, L; Boubaker, A; Casanova, M; Chastagner, P; Courbon, F; Devos, A; Di Giannatale, A; Dias-Gastellier, N; Ducassoul, S; Geoerger, B; Landman-Parker, J; Le Deley, MC; Malekzadeh, K; Mc Hugh, K; Munzer, C; Riccardi, R; Rubie, H; Verschuur, A; Zwaan, CM	1
Argnani, L; Broccoli, A; Celli, M; Derenzini, E; Pellegrini, C; Zinzani, PL	1
Barbaud, A; Bursztejn, AC; Cribier, B; Cuny, JF; Levy, E; Schmutz, JL; Schoeffler, A; Weinborn, M	1
Armitage, JO; Bartlett, NL; Bast, MA; Eastwood, DC; Fenske, TS; Havlat, L; Jewell, SW; Pingali, SR; Thompson, JR; Vose, JM; Wagner-Johnston, ND	1
Daw, S; Hayward, J; Hewitt, M; Kirkwood, A; McCarthy, K; Morland, B; Shankar, A	1
Hochhaus, A; Kunert, C; Schnetzke, U; Scholl, S; Schrenk, K; Spies-Weisshart, B	1
Enblad, G; Englund, A; Gustafsson, G; Hopstadius, C; Ljungman, G	1
Nagane, M	1
Barrington, S; Brownell, A; Counsell, N; Culligan, D; Hancock, B; Hoskin, P; Illidge, T; Johnson, P; Kruger, A; Lister, A; McMillan, A; O'Doherty, M; Pettengell, R; Popova, B; Radford, J; Smith, P; Wimperis, J	1
Datsenko, PV; Panshin, GA	1
Cassou-Mounat, T; Cayssials, E; Delwail, V; Puyade, M; Terroir, M	1
Abruzzese, E; Bocchia, M; Bono, R; Bosi, A; Cencini, E; Cox, MC; Di Lollo, S; Di Napoli, A; Fabbri, A; Fratoni, S; Gini, G; Goteri, G; Kovalchuk, S; Lazzi, S; Leoncini, L; Mancuso, S; Rigacci, L	1
Bellu, L; D'Avella, D; Della Puppa, A; Farina, M; Fiduccia, P; Lombardi, G; Pambuku, A; Zagonel, V	1
Eich, HT; Kriz, J	1
Agati, P; Agostinelli, C; Argnani, L; Biggi, A; Borra, A; Broccoli, A; d'Amore, F; Fanti, S; Fuligni, F; Gallamini, A; Gascoyne, RD; Hamilton-Dutoit, S; Kamper, P; Kulikowski, W; Levis, A; Małkowski, B; Merli, F; Patti, C; Piccaluga, PP; Pileri, SA; Rigacci, L; Romano, A; Rybka, J; Sista, MT; Steidl, C; Stelitano, C; Stracqualursi, L; Subocz, E; Tajer, J; Trentin, L; Tripodo, C; Vitolo, U; Zaucha, JM; Zinzani, PL	1
Akhtari, M; Chuang, H; Dabaja, BS; Dong, W; Fanale, M; Garg, N; Gunther, JR; Khoury, JD; Mawlawi, O; Milgrom, SA; Oki, Y; Osborne, EM; Pinnix, CC; Reddy, JP; Rohren, E; Smith, GL; Suki, T; Yehia, ZA	1
Cheung, NK; Kramer, K; Kushner, BH; Laquaglia, MP; Modak, S	1
Alves, AC; Baiocchi, OC; Oliveira, JS; Souza, EM; Zanichelli, MA	1
Csóka, M; Deák, B; Gergely, L; Illés, A; Jakab, Z; Keresztes, K; Kovács, G; Molnár, Z; Müller, J; Rosta, A; Schneider, T; Simon, Z; Várady, E	1
Egberts, F; Hauschild, A; Hitschler, WN; Weichenthal, M	1
Amistà, P; Bianchini, C; Blatt, V; Brandes, AA; Ermani, M; Faedi, M; Franceschi, E; Gardiman, M; Labianca, R; Reni, M; Santoro, A; Tosoni, A	1
Crews, KR; Daldrup-Link, HE; Groshen, S; Hawkins, RA; Jackson, HA; Maris, JM; Matthay, KK; Park, JR; Reynolds, CP; Stewart, CF; Villablanca, JG; Wagner, LM	1
Annibali, O; Avvisati, G; Cellini, F; Greco, R; Nobile, C; Petrucci, MT; Quattrocchi, CC; Tirindelli, MC	1
Ahmed, N; Katragadda, S; Ponce, D; Rasul, M; Seiter, K	1
Casey, DA; Chou, AJ; Merchant, MS; Merola, PR; Meyers, PA; Price, AP; Wexler, LH	1
Lavini, C; Majoie, CBLM; Reijneveld, JC; Richel, DJ; Stalpers, LJA; van Furth, WR; van Linde, ME; Verhoeff, JJC	1
Atkins, KA; Ferriss, JS; Jazaeri, AA; Lachance, JA; Modesitt, SC	1
Akioka, T; Hanafusa, T; Hiraoka, N; Hirata, Y; Iwaki, K; Kobayashi, K; Nakayama-Ichiyama, S; Oka, S; Takayama, A; Takubo, T; Tsuji, M; Yokote, T	1
Wen, PY	1
Bélanger, K; Easaw, J; Eisenstat, DD; Forsyth, P; Fulton, D; Kavan, P; Kirby, S; Macdonald, DR; Mason, WP; Perry, JR; Pouliot, JF; Shields, C; Thiessen, B	1
Anderson, WS; Dunn, I; Norden, A; Sure, D	1
Bigner, DD; Desjardins, A; Friedman, AH; Friedman, HS; Gururangan, S; Herndon, JE; Janney, D; Marcello, J; McLendon, RE; Peters, K; Reardon, DA; Sampson, JH; Vredenburgh, JJ	1
Baldini, L; F, FG; Ferrario, A; Goldaniga, M; Olivero, B; Radaelli, F; Rossi, F	1
Akioka, T; Hanafusa, T; Hiraoka, N; Hirata, Y; Kobayashi, K; Miyoshi, T; Nakayama, S; Oka, S; Takubo, T; Tsuji, M; Yokote, T	1
Beall, S; Brada, M; Collins, VP; Erridge, S; Gabe, R; Gattamaneni, R; Hopkins, K; Lee, SM; Levy, D; Rampling, R; Saran, F; Stenning, S; Thompson, LC	1
Chamberlain, MC	1
Aoki, T; Fujimaki, T; Itoh, K; Kajiwara, K; Kurisu, K; Mineta, T; Narita, Y; Sawamura, Y; Shibui, S; Terasaki, M; Yamada, A	1
Arizcorreta, A; Gil-Fernández, JJ; Gómez-Herruz, P; Guillen, H	1
Al Nawakil, C; Beranger, N; Brice, P; Brière, J; de Bazelaire, C; de Kerviler, E; Ertault, M; Franchi, P; Sibon, D; Thieblemont, C	1
Andresen, S; Bolwell, B; Copelan, E; Dean, R; Maragulia, JC; Moskowitz, AJ; Moskowitz, CH; Pohlman, B; Smith, SD; Sobecks, R; Sweetenham, J; Vanak, JM	1
Chinot, OL; Cloughesy, T; Das, A; de La Motte Rouge, T; Modrusan, Z; Moore, N; Phillips, H; Zeaiter, A	1
Freyschlag, CF; Lohr, F; Schmieder, K; Seiz, M; Thomé, C; Tuettenberg, J	1
Böll, B; Borchmann, P; Diehl, V; Halbsguth, TV	1
Aldape, K; Chang, SM; Chen, A; Cloughesy, TF; de Groot, JF; Deangelis, LM; Gilbert, MR; Jackson, EF; Lamborn, KR; Lassman, AB; Lieberman, F; Mehta, MP; Prados, MD; Robins, HI; Wen, PY; Yao, J; Yung, WK	1
Boström, J; Glas, M; Herrlinger, U; Kim, Y; Mack, F; Rieger, J; Schäfer, N; Scheffler, B; Simon, M; Steinbach, JP; Stuplich, M; Thanendrarajan, S; Tichy, J	1
Cunningham, D; Hawkes, EA; Wotherspoon, A	1
Andreozzi, J; Becker, M; Bernstein, SH; Constine, L; Fisher, RI; Friedberg, JW; Keller, SF; Kelly, JL; Liesveld, J; Oliva, J; Phillips, G; Rich, L; Sensenig, E	1
Chen, YH; Dosoretz, AP; Fisher, DC; Fox, AM; Freedman, AS; LaCasce, AS; Mauch, PM; Ng, AK; Silver, B	1
Eagan, P; Golfinos, JG; Gruber, D; Gruber, ML; Kunnakkat, S; Narayana, A; Parker, E; Raza, S; Zagzag, D	1
Azzoli, CG; Chan, TA; Fiore, JJ; Ginsberg, MS; Heguy, A; Holodny, AI; Huberman, K; Kadota, K; Kris, MG; Krug, LM; Pietanza, MC; Riely, GJ; Rizvi, NA; Sima, CS; Sumner, DK; Travis, WD	1
Cenci, T; D'Alessandris, QG; De Maria, R; Larocca, LM; Maira, G; Martini, M; Montano, N; Pallini, R; Pelacchi, F; Ricci-Vitiani, L	1
Filatova, LV; Gershanovich, ML; Semiglazova, TIu; Tarasenkova, AA	1
Abrey, LE; Deangelis, LM; Drappatz, J; Gilbert, MR; Nayak, L; Omuro, A; Prados, M; Reardon, DA; Wen, PY	1
Filatova, LV; Gershanovich, ML; Semiglazov, TIu; Tarasenkova, AA	1
Casini, M; Cavattoni, IM; Cortelazzo, S; Deola, S; Farsad, M; Mian, M; Pescosta, N	1
Huang, S; Huang, Z; Wu, X; Xiao, F; Yang, L; Zhang, H; Zhang, N; Zhou, A	1
Masood, N; Osmani, AH	1
Bergqvist, M; Bergström, S; Blomquist, E; Ekman, S; Henriksson, R; Johansson, F	1
Bassam, A; Nagy, KA; Pikó, B; Puskásné Szatmári, K; Török, E; Vághy, R; Vargáné Tamás, R	1
Kawai, N; Miyake, K; Okada, M; Shinomiya, A; Tamiya, T	1
Hartridge-Lambert, SK; Lim, RC; Maragulia, JC; Portlock, CS; Schöder, H	1
Aznar, MC; Maraldo, MV; Petersen, PM; Specht, L; Vogelius, IR	1
Berry, I; Cassol, E; Celsis, P; Cohen-Jonathan, EM; Delannes, M; Filleron, T; Franceries, X; Ken, S; Laprie, A; Lotterie, JA; Lubrano, V; Simon, L; Supper, C; Vieillevigne, L	1
Aguilera, D; Castellino, RC; Fangusaro, J; Hayes, LL; Kim, S; MacDonald, TJ; Mazewski, C; McNall-Knapp, RY	1
Amistà, P; Basso, U; Berti, F; Brandes, AA; Ermani, M; Gardiman, M; Iuzzolino, P; Lumachi, F; Monfardini, S; Paris, MK; Turazzi, S	1
Chiamchanya, S; Dhanachai, M; Hongeng, S; Laothamatus, J; Visudtibhan, A	1
Caglevic, C; Osorio, G	1
Boissevain, F; De Wit, M; Diehl, V; Duhmke, E; Engert, A; Hasenclever, D; Herrmann, R; Josting, A; Koch, P; Loffler, M; Mezger, J; Muller, RP; Muller-Hermelink, HK; Pfistner, B; Renner, H; Schiller, P; Schmidt, BF; Sieber, M; Willich, N; Wolf, J	1
Amoateng-Adjepong, Y; Haddad, RG; Upadya, A	1
Crump, M; Gospodarowicz, MK; Hodgson, DC; Pintilie, M; Sun, A; Tsang, RW; Wells, W	1
Gardembas-Pain, M; Mege, M; Pabot du Chatelard, P	1
Fisher, DC; Li, S; Mauch, PM; Neuberg, D; Ng, AK; Silver, B; Stevenson, MA	1
Anargyrou, K; Angelopoulou, MK; Boussiotis, VA; Boutsis, DE; Dimopoulou, MN; Karkantaris, C; Kokoris, SI; Kontopidou, FN; Kyrtsonis, MC; Michalopoulos, T; Panayiotidis, P; Pangalis, GA; Papavassiliou, C; Siakantaris, MP; Tsaftaridis, P; Variamis, E; Vassilakopoulos, TP	1
Atahan, IL; Barista, I; Caglar, M; Caner, B; Cengiz, M; Engin, H; Güllü, I; Gürkaynak, M; Ozyar, E; Tekuzman, G; Yildiz, F; Zengin, N; Zorlu, F	1
Alba, E; de Las Nieves, MA; Gumá, J; Herrero, J; Llanos, M; Márquez, A; Miramón, J; Rueda Domínguez, A	1
Arya, LS; Bakhshi, S; Dawar, R; Dinand, V; Singh, R; Thavaraj, V	1
Bernardo, MV; Fisher, DC; Mauch, PM; Ng, AK; Silver, B; Stevenson, MA; Van Den Abbeele, A	1
Balcerska, A; Balwierz, W; Chybicka, A; Depowska, T; Drozyńska, E; Kaczmarek-Kanold, M; Klekawka, T; Kowalczyk, J; Kołakowska-Mrozowska, B; Kołtan, A; Krawczuk-Rybak, M; Krenke, K; Matysiak, M; Moryl-Bujakowska, A; Moszant, A; Odój, T; Raś, M; Sońta-Jakimczyk, D; Sopyło, B; Stanuch, H; Stolarska, M; Wachowiak, J; Wysocki, M	2
Bernard Hesseling, P; Wessels, G	1
Jost, LM; Stahel, RA	1
Hallinen, T; Kivioja, A; Martikainen, JA; Vihinen, P	1
Campbell, B; Di Iulio, J; MacManus, M; Milner, A; Ryan, G; Wirth, A	1
Bökkerink, JP; Claviez, A; Dörffel, W; Körholz, D; Lüders, H; Mann, G; Pötter, R; Riepenhausen, M; Rühl, U; Scheel-Walter, HG; Schellong, G	1
Abrey, LE; Demopoulos, A; Franceschi, E; Lassman, AB; Nolan, C; Omuro, AM	1
Alpert, TE; Hatoum, GF; Morbidini-Gaffney, S; Sagerman, RH	1
Audebert, F; Hartmann, P; Kullmann, F; Schneidewind, A; Schölmerich, J	1
Han, JZ; Jin, J; Li, YX; Liu, XF; Liu, YP; Song, YW; Wang, SL; Wang, WH; Yu, ZH; Zhou, LQ	1
Mutter, N; Stupp, R	1
Beishuizen, A; de Man, R; Lam, KH; Pieters, R; van den Heuvel-Eibrink, MM; van Grotel, M	1
Corrado, C; Greco, M; Niccodemi, C; Presas, J; Valsecchi, M; Winkel, M	1
Arora, M; Burns, LJ; Defor, TE; MacMillan, ML; Majhail, NS; McGlave, PB; Miller, JS; Orchard, PJ; Ramsay, NK; Slungaard, A; Weisdorf, DJ	1
Eich, HT; Müller, RP	1
Crippa, C; Facchetti, F; Ferrari, S; Frata, P; Grazioli, L; Magrini, SM; Pizzocaro, C; Re, A; Rossi, G; Tucci, A	1
Arlen, M; Cohen, M; Hollinshead, A; Kundin, WD; Scherrer, J; Tanner, K; Yonemoto, R	1
al-Katib, A; Andersen, J; Bishop, CR; Hussein, ME; Karanes, C; Khanuja, PS; Smith, MR	1
Alessandrino, EP; Astori, C; Bernasconi, P; Brusamolino, E; Canevari, A; Castelli, G; Lazzarino, M; Morra, E; Orlandi, E; Pagnucco, G	1
Bohndorf, W; Freitag, EM; Ganser, D; Mjaaland, I	1
Canellos, G; Coleman, CN; Mauch, P; Rosenthal, DS; Shulman, LN; Silver, B; Tarbell, NJ; Uematsu, M; Weinstein, H	1
Bader, SB; Mauch, P; Silver, B; Tarbell, NJ; Weinstein, H	1
Aversa, SM; Bianco, A; Chiarion Sileni, V; Fiorentino, MV; Pappagallo, GL; Salvagno, L; Sorarù, M	1
Abdallah, JM; Kirsch, IR; Lombardi, DP	1
Horning, SJ; Yuen, AR	1
Goldberg, SL; Klumpp, TR; Mangan, KF; Ming, PL; Mullaney, MT; Rao, PN; Redei, I	1
Bartels, H; Cartoni, C; Diehl, V; Dölken, G; Enzian, J; Franklin, J; Fuchs, R; Gassmann, W; Geilen, W; Gerhartz, H; Hagen-Aukamp, U; Hasenclever, D; Hiller, E; Hinkelbein, H; Hinterberger, W; Kirchner, H; Koch, P; Krüger, B; Loeffler, M; Nisters-Backes, H; Pfreundschuh, M; Rühl, U; Schwarze, EW; Sieber, M; Tesch, H	1
Cantor, A; Gieser, P; Green, D; Jenkins, JJ; Marcus, RB; Maurer, HM; Neff, J; Parham, D; Pick, T; Pratt, CB; Rao, BN; Salzberg, A; Thomas, PR	1
Ariyan, S; Poo, WJ	1
Balzarotti, M; Bonadonna, G; Bonfante, V; Camerini, E; Devizzi, L; Fornier, M; Santoro, A; Valagussa, P; Verderio, P; Viviani, S	1
Busch, R; Dengler, R; Eger, G; Emmerich, B; Münstermann, U; Plewan, A	1
Bamberg, M; Becker, G; Belka, C; Classen, J; Hoffmann, W; Kortmann, RD; Paulsen, F; Weinmann, M	1
Armata, J; Balwierz, W; Bogusławska-Jaworska, J; Janik-Moszant, A; Kaczmarek-Kanold, M; Kowalczyk, J; Kołakowska-Mrozowska, B; Kołecki, P; Matysiak, M; Moryl-Bujakowska, A; Newecka-Samól, T; Pisarek, J; Rokicka-Milewska, R; Skomra, S; Soñta-Jakimczyk, D; Sopyło, B	1
Anselmo, AP; Donato, V; Enrici, RM; Falchetto Osti, M; Mandelli, F; Santoro, M; Tombolini, V	1
Aravantinos, G; Christodoulou, C; Efstathiou, E; Janinis, J; Panopoulos, C; Samantas, E; Skarlos, D	1
Atkins, MB; Clancy, MA; Lawrence, DP; McDermott, DF; Mier, JW; Rubin, KM; van den Brink, MR	1
Albright, RE; Brada, M; Bruner, J; Fink, K; Fredericks, R; Friedman, H; Glantz, M; Greenberg, H; Hohl, RJ; Levin, VA; Olson, J; Osoba, D; Phillips, P; Prados, MD; Rampling, R; Selker, RG; Shapiro, W; Spence, A; Vick, NA; Yue, N; Yung, WK; Zaknoen, S	1
Avigdor, A; Ben-Bassat, I; Grotto, I; Hardan, I; Raanani, P; Shpilberg, O	1
Christophers, E; Hauschild, A; Lischner, S; Möller, M	1
Blumental, R; Ducach, A; Lugassy, G; Maslovsky, I; Volchek, L	1
Cave, C; Dinnes, J; Huang, S; Major, K; Milne, R	1
Kennedy, RD; McAleer, JJ	1
Bellet, RE; Berkelhammer, J; Mastrangelo, MJ; Prehn, RT; Thibault, LH	1
Bertrand, Y; Bey, P; Chompret, A; Habrand, JL; Leverger, G; Oberlin, O; Pacquement, H; Raquin, MA; Rubie, H; Terrier-Lacombe, MJ	1
Brice, P; Brouet, JC; Castaigne, S; D'Agay, MF; Fermand, JP; Fermé, C; Frija, J; Lepage, E; Marty, M; Miot, C	1
Bonadonna, G; Bonfante, V; Negretti, E; Santoro, A; Valagussa, P; Viviani, S	1
Bonadonna, G; Negretti, E; Santoro, A; Valagussa, P; Viviani, S; Zanini, M; Zucali, R	1
Breed, WP; Burgers, JM; Carde, P; de Pauw, BE; Hagenbeek, A; Henry-Amar, M; Monconduit, M; Somers, R; Tarayre, M; Thomas, J	1
Bonadonna, G; Santoro, A; Valagussa, P	1
Rusthoven, JJ	1
Burgers, JM; Carde, P; Hayat, M; Henry-Amar, M; Meerwaldt, JH; Noordijk, EM; Tanguy, A; Thomas, J; Tubiana, M; Van der Schueren, E	1

Reviews

12 review(s) available for dacarbazine and Recrudescence

Article	Year
Emerging role of novel therapies in Hodgkin lymphoma: proceed with caution. Hematology. American Society of Hematology. Education Program, 2017, 12-08, Volume: 2017, Issue:1 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Brentuximab Vedotin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Immunoconjugates; Neoplasm Proteins; Nivolumab; Programmed Cell Death 1 Receptor; Recurrence; Vinblastine	2017
Determining the sequence of novel therapies in the treatment of relapsed Hodgkin's lymphoma. Expert review of hematology, 2018, Volume: 11, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Immunoconjugates; Male; Recurrence; United States; Vinblastine	2018
Dose-dense temozolomide: is it still promising? Neurologia medico-chirurgica, 2015, Volume: 55, Issue:1 Topics: Antineoplastic Agents, Alkylating; Clinical Trials as Topic; Dacarbazine; Disease Progression; Dose-Response Relationship, Drug; Glioblastoma; Humans; Recurrence; Temozolomide	2015
Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas. Expert review of neurotherapeutics, 2010, Volume: 10, Issue:10 Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Drug Resistance, Neoplasm; Female; Glioblastoma; Glioma; Humans; Male; Palliative Care; Recurrence; Temozolomide; Treatment Outcome	2010
The unique characteristics and management of patients over 60 years of age with classic Hodgkin lymphoma. Current hematologic malignancy reports, 2011, Volume: 6, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Comorbidity; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Middle Aged; Recurrence; Vinblastine	2011
The unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: current approaches to diagnosis and management. Leukemia & lymphoma, 2012, Volume: 53, Issue:3 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Histiocytes; Hodgkin Disease; Humans; Immunophenotyping; Lymph Node Excision; Lymphatic Irradiation; Lymphocytes; Prognosis; Recurrence; Rituximab; Salvage Therapy; Vinblastine	2012
[Use of angioneogenesis inhibitor monoclonal antibody following standard therapy in recurrent or progressive glioblastoma multiforme]. Magyar onkologia, 2012, Volume: 56, Issue:3 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Bevacizumab; Brain Neoplasms; Camptothecin; Dacarbazine; Disease Progression; Drug Approval; Europe; Glioblastoma; Humans; Hungary; Irinotecan; Magnetic Resonance Imaging; Off-Label Use; Recurrence; Temozolomide; Treatment Outcome	2012
Perspectives of the management of childhood lymphoma: experience at Tygerberg Hospital, Western Cape, South Africa. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2005, Volume: 32, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Transfusion; Child; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Recurrence; South Africa; Time Factors; Vinblastine; Vincristine	2005
Temozolomide: a milestone in neuro-oncology and beyond? Expert review of anticancer therapy, 2006, Volume: 6, Issue:8 Topics: Antineoplastic Agents, Alkylating; Base Pair Mismatch; Brain Neoplasms; Clinical Trials, Phase II as Topic; Dacarbazine; Glioma; Humans; Recurrence; Temozolomide	2006
Hodgkin's disease: management of first relapse. Oncology (Williston Park, N.Y.), 1996, Volume: 10, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Prognosis; Recurrence; Salvage Therapy; Time Factors; Transplantation, Autologous; Vinblastine; Vincristine	1996
The effectiveness and cost-effectiveness of temozolomide for the treatment of recurrent malignant glioma: a rapid and systematic review. Health technology assessment (Winchester, England), 2001, Volume: 5, Issue:13 Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Cost-Benefit Analysis; Dacarbazine; Evidence-Based Medicine; Glioma; Humans; Recurrence; Temozolomide; Treatment Outcome; United Kingdom	2001
Current approaches to the treatment of advanced-stage Hodgkin's disease. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1986, Sep-01, Volume: 135, Issue:5 Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Administration Schedule; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Recurrence; Vinblastine; Vincristine	1986

Trials

43 trial(s) available for dacarbazine and Recrudescence

Article	Year
Involved-Field Radiation Therapy Prevents Recurrences in the Early Stages of Hodgkin Lymphoma in PET-Negative Patients After ABVD Chemotherapy: Relapse Analysis of GHSG Phase 3 HD16 Trial. International journal of radiation oncology, biology, physics, 2021, 11-15, Volume: 111, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chronic Disease; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Recurrence; Vinblastine	2021
Salvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini-Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Phase 2 Clinical Trial. JAMA oncology, 2018, Feb-01, Volume: 4, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Female; Hematopoietic Stem Cell Transplantation; Humans; Inotuzumab Ozogamicin; Male; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Salvage Therapy; Survival Analysis; Vincristine; Young Adult	2018
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium study. Pediatric blood & cancer, 2013, Volume: 60, Issue:9 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Dose-Response Relationship, Drug; Female; Histones; Humans; Hydroxamic Acids; Leukocytes, Mononuclear; Male; Maximum Tolerated Dose; Neutropenia; Promoter Regions, Genetic; Recurrence; Spinal Cord Neoplasms; Temozolomide; Thrombocytopenia; Tumor Suppressor Proteins; Vorinostat	2013
A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors. PloS one, 2013, Volume: 8, Issue:7 Topics: Adolescent; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Camptothecin; Child; Child, Preschool; Dacarbazine; Dose-Response Relationship, Drug; Female; Humans; Irinotecan; Male; Maximum Tolerated Dose; Neoplasms; Recurrence; Temozolomide; Vincristine; Young Adult	2013
Sorafenib plus daily low-dose temozolomide for relapsed glioblastoma: a phase II study. Anticancer research, 2013, Volume: 33, Issue:8 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Recurrence; Sorafenib; Survival Analysis; Temozolomide; Time Factors	2013
Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: a European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study. European journal of cancer (Oxford, England : 1990), 2014, Volume: 50, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dacarbazine; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Neuroblastoma; Recurrence; Temozolomide; Topotecan; Young Adult	2014
Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma. The New England journal of medicine, 2015, Apr-23, Volume: 372, Issue:17 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease Progression; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Recurrence; Survival Analysis; Vinblastine; Young Adult	2015
[No general recommendation for waiving consolidated radiotherapy in Hodgkin lymphoma and negative PET results after completion of chemotherapy]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2016, Volume: 192, Issue:8 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease Progression; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Proportional Hazards Models; Recurrence; Survival Analysis; Survival Rate; Treatment Outcome; United Kingdom; Vinblastine; Young Adult	2016
Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapse. Melanoma research, 2009, Volume: 19, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Interferon alpha-2; Interferon-alpha; L-Lactate Dehydrogenase; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Nerve Growth Factors; Prospective Studies; Recombinant Proteins; Recurrence; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Skin Neoplasms; Vindesine	2009
Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO). Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Humans; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Recurrence; Temozolomide	2009
Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Mar-10, Volume: 27, Issue:8 Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Child; Child, Preschool; Dacarbazine; Female; Genotype; Glucuronosyltransferase; Humans; Irinotecan; Male; Maximum Tolerated Dose; Neuroblastoma; Recurrence; Temozolomide	2009
Temozolomide and cisplatin in relapsed/refractory acute leukemia. Journal of hematology & oncology, 2009, May-22, Volume: 2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Drug Resistance, Neoplasm; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Salvage Therapy; Temozolomide; Treatment Failure; Young Adult	2009
Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience. Pediatric blood & cancer, 2009, Volume: 53, Issue:6 Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Camptothecin; Child; Child, Preschool; Colitis; Dacarbazine; Diarrhea; Female; Humans; Irinotecan; Male; Neutropenia; Pneumonia; Recurrence; Remission Induction; Retrospective Studies; Sarcoma, Ewing; Temozolomide; Thrombocytopenia; Young Adult	2009
Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Apr-20, Volume: 28, Issue:12 Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Canada; Chemotherapy, Adjuvant; Dacarbazine; Disease Progression; Disease-Free Survival; Female; Glioblastoma; Glioma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prospective Studies; Radiotherapy, Adjuvant; Recurrence; Temozolomide; Time Factors; Treatment Outcome	2010
Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma. Journal of neuro-oncology, 2011, Volume: 101, Issue:1 Topics: Adult; Aged; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Brain Neoplasms; Cytochrome P-450 CYP3A; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Niacinamide; Phenylurea Compounds; Pyridines; Recurrence; Sorafenib; Temozolomide	2011
Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Oct-20, Volume: 28, Issue:30 Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Female; Glioma; Humans; Kaplan-Meier Estimate; Lomustine; Male; Middle Aged; Neoplasm Staging; Procarbazine; Proportional Hazards Models; Quality of Life; Recurrence; Risk Assessment; Risk Factors; Temozolomide; Time Factors; Treatment Outcome; United Kingdom; Vincristine	2010
Phase I trial of a personalized peptide vaccine for patients positive for human leukocyte antigen--A24 with recurrent or progressive glioblastoma multiforme. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jan-20, Volume: 29, Issue:3 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Cancer Vaccines; Central Nervous System Neoplasms; Dacarbazine; Dose-Response Relationship, Immunologic; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Glioblastoma; HLA-A Antigens; HLA-A24 Antigen; Humans; Japan; Male; Middle Aged; Precision Medicine; Recurrence; Survival Analysis; T-Lymphocytes, Cytotoxic; Temozolomide; Vaccines, Subunit	2011
Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients. British journal of haematology, 2011, Volume: 153, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Recurrence; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Vinblastine	2011
AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme. Advances in therapy, 2011, Volume: 28, Issue:4 Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Alkylating; Bevacizumab; Brain Neoplasms; Clinical Protocols; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Dacarbazine; Europe; Glioblastoma; Humans; Prognosis; Radiotherapy; Recurrence; Standard of Care; Temozolomide; Treatment Outcome	2011
Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jul-01, Volume: 29, Issue:19 Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Chemotherapy, Adjuvant; Cohort Studies; Dacarbazine; Disease Progression; Disease-Free Survival; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; North America; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Recurrence; Temozolomide; Vascular Endothelial Growth Factor A	2011
A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma. Journal of neurosurgery, 2012, Volume: 116, Issue:2 Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Alkylating; Bevacizumab; Brain Neoplasms; Chemoradiotherapy; Dacarbazine; Disease-Free Survival; Drug Therapy, Combination; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Morbidity; Prognosis; Recurrence; Temozolomide; Treatment Outcome	2012
Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Feb-15, Volume: 18, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Dacarbazine; DNA Methylation; Female; Humans; Lung Neoplasms; Male; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Promoter Regions, Genetic; Recurrence; Small Cell Lung Carcinoma; Survival Analysis; Temozolomide; Treatment Outcome	2012
Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma. Leukemia & lymphoma, 2013, Volume: 54, Issue:1 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Dacarbazine; Female; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Recurrence; Rituximab; Salvage Therapy; Temozolomide; Treatment Outcome	2013
Temozolomide in patients with glioblastoma at second relapse after first line nitrosourea-procarbazine failure: a phase II study. Oncology, 2002, Volume: 63, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Glioblastoma; Humans; Male; Middle Aged; Nitrosourea Compounds; Procarbazine; Recurrence; Survival Rate; Temozolomide; Treatment Outcome	2002
Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymph Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Oct-01, Volume: 21, Issue:19 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease Progression; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy; Recurrence; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine	2003
Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin's disease. Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Recurrence; Salvage Therapy; Vinblastine; Vincristine	2004
Treatment of stage I and II Hodgkin's lymphoma with ABVD chemotherapy: results after 7 years of a prospective study. Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Recurrence; Treatment Outcome; Vinblastine	2004
Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Citrates; Combined Modality Therapy; Dacarbazine; Disease Management; Disease-Free Survival; Doxorubicin; Female; Gallium; Gallium Radioisotopes; Hodgkin Disease; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Recurrence; Risk; Tomography, X-Ray Computed; Vinblastine	2008
ABMT recommended for relapsed Hodgkin's disease, but better overall survival not yet proved. Oncology (Williston Park, N.Y.), 1996, Volume: 10, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Recurrence; Remission Induction; Salvage Therapy; Treatment Outcome; Vinblastine; Vincristine	1996
Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Radiation; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Proportional Hazards Models; Recurrence; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine	1997
Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: a Pediatric Oncology Group study. Medical and pediatric oncology, 1998, Volume: 30, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Recurrence; Sarcoma; Soft Tissue Neoplasms; Vincristine	1998
Chemotherapy in the treatment of recurrent glioblastoma multiforme: ifosfamide versus temozolomide. Journal of cancer research and clinical oncology, 1999, Volume: 125, Issue:7 Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Disease Progression; Drug Administration Schedule; Female; Glioblastoma; Humans; Ifosfamide; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Analysis; Temozolomide; Treatment Outcome	1999
Childhood stage IV Hodgkin disease: therapeutic results of the Polish pediatric leukemia/lymphoma study group. Medical and pediatric oncology, 1999, Volume: 33, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Poland; Prednisolone; Prednisone; Procarbazine; Recurrence; Time Factors; Treatment Outcome; Vinblastine; Vincristine	1999
Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD. Haematologica, 1999, Volume: 84, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mediastinal Neoplasms; Middle Aged; Recurrence; Survival Rate; Vinblastine	1999
Phase II study of temozolomide in patients with relapsing high grade glioma and poor performance status. Medical oncology (Northwood, London, England), 2000, Volume: 17, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Glioma; Humans; Male; Middle Aged; Recurrence; Temozolomide	2000
A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin 2, and interferon alpha-2B in patients with metastatic melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cisplatin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-2; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Pilot Projects; Recombinant Proteins; Recurrence; Time Factors; Treatment Outcome; Vinblastine	2000
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. British journal of cancer, 2000, Volume: 83, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Gliosarcoma; Humans; Male; Middle Aged; Procarbazine; Prognosis; Quality of Life; Recurrence; Temozolomide; Time Factors	2000
Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:10 Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Radiotherapy Dosage; Recurrence; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine	1992
Hodgkin's disease, clinical stages I, II A-B and IIIA. Results of brief chemotherapy followed by irradiation. Nouvelle revue francaise d'hematologie, 1992, Volume: 34, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Procarbazine; Prospective Studies; Recurrence; Survival Rate; Vinblastine; Vincristine	1992
Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience. Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2 Suppl 2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphatic Metastasis; Male; Mechlorethamine; Neoplasms, Multiple Primary; Patient Compliance; Prednisone; Procarbazine; Prospective Studies; Radiotherapy Dosage; Recurrence; Remission Induction; Survival Rate; Vinblastine; Vincristine	1991
Management of relapse and survival in advanced stage Hodgkin's disease: the EORTC experience. Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2 Suppl 2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Recurrence; Remission Induction; Survival Rate; Vinblastine; Vincristine	1991
Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results. Annals of internal medicine, 1986, Volume: 104, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednimustine; Prednisone; Procarbazine; Prospective Studies; Random Allocation; Recurrence; Vinblastine; Vincristine	1986
Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987. Blood, 1989, Volume: 73, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Europe; Follow-Up Studies; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Random Allocation; Recurrence; Vinblastine; Vincristine	1989

Other Studies

91 other study(ies) available for dacarbazine and Recrudescence

Article	Year
Evaluation of the Relapse Risk and Survival Rate in Patients with Hodgkin Lymphoma: A Monocentric Experience. Medicina (Kaunas, Lithuania), 2021, Sep-27, Volume: 57, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Middle Aged; Recurrence; Survival Rate; Treatment Outcome; Vinblastine; Young Adult	2021
Relapse patterns in early-PET negative, limited-stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy-a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trials. British journal of haematology, 2023, Volume: 200, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Vinblastine	2023
Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2020, Volume: 24, Issue:3 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Organs at Risk; Prednisone; Procarbazine; Radiotherapy Dosage; Recurrence; Retrospective Studies; Treatment Outcome; Tunisia; Vinblastine; Vincristine; Young Adult	2020
Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021, 01-10, Volume: 39, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Progression-Free Survival; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Stem Cell Transplantation; Treatment Outcome; Vinblastine; Vincristine; Young Adult	2021
Temozolomide alone or in combination with doxorubicin as a rescue agent in 37 cases of canine multicentric lymphoma. Veterinary and comparative oncology, 2018, Volume: 16, Issue:2 Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Databases, Factual; Dog Diseases; Dogs; Doxorubicin; Kaplan-Meier Estimate; Lymphoma; Recurrence; Retrospective Studies; Survival; Temozolomide; Treatment Outcome; United Kingdom	2018
Early-stage Hodgkin lymphoma outcomes after combined modality therapy according to the post-chemotherapy 5-point score: can residual pet-positive disease be cured with radiotherapy alone? British journal of haematology, 2017, Volume: 179, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease Progression; Doxorubicin; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Patient Selection; Positron Emission Tomography Computed Tomography; Radiotherapy; Radiotherapy Dosage; Recurrence; Retrospective Studies; Risk Factors; Salvage Therapy; Treatment Outcome; Vinblastine; Young Adult	2017
Prolonged administration of adjuvant temozolomide improves survival in adult patients with glioblastoma. Anticancer research, 2013, Volume: 33, Issue:8 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Humans; Male; Middle Aged; Recurrence; Temozolomide; Treatment Outcome; Young Adult	2013
Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution. BMC cancer, 2013, Sep-03, Volume: 13 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Female; Glioblastoma; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Prognosis; Recurrence; Reoperation; Risk Factors; Temozolomide; Treatment Outcome; Young Adult	2013
Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin. British journal of haematology, 2013, Volume: 163, Issue:5 Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bleomycin; Brentuximab Vedotin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Resistance, Neoplasm; Hodgkin Disease; Humans; Immunoconjugates; Male; Nitrogen Mustard Compounds; Positron-Emission Tomography; Radiotherapy, Adjuvant; Recurrence; Salvage Therapy; Vinblastine; Young Adult	2013
[Stevens-Johnson syndrome and Hodgkin's disease: A fortuitous association or paraneoplastic syndrome?]. Annales de dermatologie et de venereologie, 2014, Volume: 141, Issue:2 Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Causality; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Male; Neoplasm Staging; Paraneoplastic Syndromes; Prednisone; Procarbazine; Recurrence; Remission Induction; Stevens-Johnson Syndrome; Vinblastine; Vincristine; Young Adult	2014
Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission. Cancer, 2014, Jul-15, Volume: 120, Issue:14 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Dacarbazine; Direct Service Costs; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Induction Chemotherapy; Male; Middle Aged; Population Surveillance; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed; United States; Vinblastine	2014
Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy. British journal of haematology, 2014, Volume: 165, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Chlorambucil; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Melphalan; Multicenter Studies as Topic; Neoplasm Staging; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vinblastine; Vincristine	2014
Different clones of acute leukemia after successful treatment of Hodgkin's disease. Annals of hematology, 2014, Volume: 93, Issue:12 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Azacitidine; Bleomycin; Bone Marrow; Clone Cells; Consolidation Chemotherapy; Dacarbazine; Doxorubicin; Fatal Outcome; Female; fms-Like Tyrosine Kinase 3; Hodgkin Disease; Humans; Immunophenotyping; Leukemia, Myelomonocytic, Acute; Neoplasm Proteins; Neoplasms, Second Primary; Neoplastic Stem Cells; Palliative Care; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Salvage Therapy; Vinblastine	2014
Hodgkin lymphoma--a survey of children and adolescents treated in Sweden 1985-2009. Acta oncologica (Stockholm, Sweden), 2015, Volume: 54, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Incidence; Infant; Infant, Newborn; Male; Mechlorethamine; Prednisone; Procarbazine; Recurrence; Sex Distribution; Survival Analysis; Sweden; Vinblastine; Vincristine	2015
[Hodgkin's lymphoma and radiotherapy]. Voprosy onkologii, 2015, Volume: 61, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Radiation Injuries; Radiotherapy Dosage; Recurrence; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine	2015
Use of temozolomide instead of cyclophosphamide in diffuse large B-cell lymphoma. Leukemia & lymphoma, 2016, Volume: 57, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Dacarbazine; Drug Hypersensitivity; Drug Substitution; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Immunophenotyping; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Recurrence; Temozolomide; Treatment Outcome; Young Adult	2016
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment. Hematological oncology, 2017, Volume: 35, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Immunohistochemistry; Macrophages; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Recurrence; Treatment Outcome; Vinblastine; Young Adult	2017
Clinical outcome of an alternative fotemustine schedule in elderly patients with recurrent glioblastoma: a mono-institutional retrospective study. Journal of neuro-oncology, 2016, Volume: 128, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Brain Neoplasms; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Drug Administration Schedule; Female; Humans; Male; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Recurrence; Retrospective Studies; Survival Analysis; Temozolomide; Treatment Outcome; Tumor Suppressor Proteins	2016
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study. The Lancet. Haematology, 2016, Volume: 3, Issue:10 Topics: Adult; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Cohort Studies; Dacarbazine; Denmark; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Italy; Male; Multivariate Analysis; Poland; Positron-Emission Tomography; Programmed Cell Death 1 Receptor; Recurrence; Reed-Sternberg Cells; Retrospective Studies; STAT1 Transcription Factor; Treatment Failure; Tumor Microenvironment; Vinblastine	2016
Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville Score. International journal of radiation oncology, biology, physics, 2017, 02-01, Volume: 97, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Confidence Intervals; Dacarbazine; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Glycolysis; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Recurrence; Risk; Treatment Outcome; Tumor Burden; Vinblastine	2017
Recurrent metastatic neuroblastoma followed by myelodysplastic syndrome: possible leukemogenic role of temozolomide. Pediatric blood & cancer, 2008, Volume: 51, Issue:4 Topics: Adolescent; Adult; Cell Transformation, Neoplastic; Child; Combined Modality Therapy; Dacarbazine; Female; Humans; Myelodysplastic Syndromes; Neoplasm Metastasis; Neuroblastoma; Recurrence; Temozolomide	2008
Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study. Annals of hematology, 2009, Volume: 88, Issue:7 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Dacarbazine; Doxorubicin; Drug Evaluation; Female; Follow-Up Studies; Hodgkin Disease; Hospitals, Urban; Humans; Male; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Prednisone; Procarbazine; Recurrence; Remission Induction; Retrospective Studies; Survival Analysis; Vinblastine; Vincristine; Young Adult	2009
[Hodgkin's lymphoma in adolescents: where to treat it--in an adult or pediatric institution?]. Orvosi hetilap, 2008, Nov-23, Volume: 149, Issue:47 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cancer Care Facilities; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Hungary; Male; Neoplasm Staging; Prednisone; Procarbazine; Recurrence; Retrospective Studies; Survival Analysis; Vinblastine; Vincristine; Young Adult	2008
The combination topotecan, temozolomide and dexamethasone associated with radiotherapy as treatment of central nervous system myeloma relapse. International journal of hematology, 2009, Volume: 89, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Dacarbazine; Dexamethasone; Fatal Outcome; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Multiple Myeloma; Recurrence; Temozolomide; Topotecan	2009
Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma. Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:8 Topics: Adolescent; Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Brain Neoplasms; Dacarbazine; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glioma; Humans; Male; Middle Aged; Recurrence; Temozolomide; Treatment Outcome; Young Adult	2010
Temozolomide in advanced and recurrent uterine leiomyosarcoma and correlation with o6-methylguanine DNA methyltransferase expression: a case series. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2010, Volume: 20, Issue:1 Topics: Adult; Antineoplastic Agents, Alkylating; Biomarkers, Pharmacological; Biomarkers, Tumor; Dacarbazine; Disease Progression; Female; Follow-Up Studies; Humans; Leiomyosarcoma; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Prognosis; Recurrence; Retrospective Studies; Temozolomide; Uterine Neoplasms	2010
Multiple-cytokine-producing, mixed-cellularity, classical Hodgkin lymphoma with B symptoms and minimal-change nephrotic syndrome. Leukemia research, 2010, Volume: 34, Issue:7 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; C-Reactive Protein; Dacarbazine; Doxorubicin; Edema; Fatigue; Fever; Hodgkin Disease; Humans; Immunosuppressive Agents; Interleukin-6; Male; Nephrosis, Lipoid; Paraneoplastic Syndromes; Recurrence; Reed-Sternberg Cells; Sweating; Tumor Necrosis Factor-alpha; Vinblastine	2010
Therapy for recurrent high-grade gliomas: does continuous dose-intense temozolomide have a role? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Apr-20, Volume: 28, Issue:12 Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Disease Progression; Disease-Free Survival; Glioma; Humans; Radiotherapy, Adjuvant; Recurrence; Temozolomide; Time Factors; Treatment Outcome	2010
Intracerebral hemorrhage secondary to thrombocytopenia in a patient treated with temozolomide. Clinical neurology and neurosurgery, 2010, Volume: 112, Issue:8 Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cerebral Hemorrhage; Dacarbazine; Dose-Response Relationship, Drug; Fatal Outcome; Glioma; Humans; Male; Recurrence; Temozolomide; Thrombocytopenia	2010
ABVD associated with imatinib for coexisting chronic myeloid leukaemia and relapsed Hodgkin lymphoma. Leukemia research, 2010, Volume: 34, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pyrimidines; Recurrence; Vinblastine	2010
Minimal-change nephrotic syndrome preceding Hodgkin lymphoma by 5 years with expression of tumor necrosis factor alpha in Hodgkin-Reed-Sternberg cells. Human pathology, 2010, Volume: 41, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Male; Nephrosis, Lipoid; Recurrence; Reed-Sternberg Cells; Tumor Necrosis Factor-alpha; Vinblastine	2010
[Fatal Bacillus cereus sepsis and rhabdomyolysis in a patient with Hodgkin's disease]. Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bacillus cereus; Bacteremia; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Diabetes Mellitus, Type 2; Disease Susceptibility; Doxorubicin; Fatal Outcome; Female; Gram-Positive Bacterial Infections; Hodgkin Disease; Humans; Immunocompromised Host; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Recurrence; Rhabdomyolysis; Shock, Septic; Vinblastine; Vincristine	2011
Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centres. British journal of haematology, 2011, Volume: 153, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Epidemiologic Methods; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Middle Aged; Prognosis; Recurrence; Treatment Outcome; Vinblastine; Young Adult	2011
Response to temozolomide in supratentorial multifocal recurrence of malignant ependymoma. Anticancer research, 2011, Volume: 31, Issue:3 Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Dacarbazine; Disease Progression; Ependymoma; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Recurrence; Supratentorial Neoplasms; Temozolomide; Treatment Outcome	2011
Ifosfamide, carboplatin and etoposide in recurrent malignant glioma. Oncology, 2011, Volume: 80, Issue:5-6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Dacarbazine; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Ifosfamide; Male; Middle Aged; Recurrence; Retrospective Studies; Temozolomide; Treatment Failure	2011
Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic era. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2012, Volume: 18, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease Management; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Middle Aged; Recurrence; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Vinblastine	2012
Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapy. International journal of radiation oncology, biology, physics, 2012, May-01, Volume: 83, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Lung; Lung Transplantation; Male; Middle Aged; Radiation Pneumonitis; Radiotherapy Dosage; Radiotherapy, Conformal; Recurrence; Risk Assessment; Vinblastine; Young Adult	2012
Expression of EGFRvIII in glioblastoma: prognostic significance revisited. Neoplasia (New York, N.Y.), 2011, Volume: 13, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Dacarbazine; ErbB Receptors; Female; Gene Expression; Glioblastoma; Humans; Male; Middle Aged; Prognosis; Recurrence; Spheroids, Cellular; Survival Analysis; Temozolomide; Tumor Cells, Cultured; Young Adult	2011
[Primary refractory and relapsed Hodgkin lymphoma with unfavorable prognosis]. Voprosy onkologii, 2012, Volume: 58, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome; Vinblastine; Vincristine	2012
[Relapse in Hodgkin lymphoma]. Voprosy onkologii, 2012, Volume: 58, Issue:2 Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prednisone; Procarbazine; Prognosis; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; Serum Albumin; Treatment Outcome; Vinblastine; Vincristine	2012
Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation. Annals of hematology, 2013, Volume: 92, Issue:1 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bleomycin; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Deoxycytidine; Doxorubicin; Etoposide; Fatal Outcome; Female; Gemcitabine; Graft vs Host Disease; Hodgkin Disease; Humans; Ifosfamide; Male; Nitrogen Mustard Compounds; Prednisolone; Prednisone; Procarbazine; Recurrence; Reoperation; Rituximab; Salvage Therapy; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine; Vinorelbine; Young Adult	2013
FoxM1 inhibition sensitizes resistant glioblastoma cells to temozolomide by downregulating the expression of DNA-repair gene Rad51. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Nov-01, Volume: 18, Issue:21 Topics: Antineoplastic Agents, Alkylating; Binding Sites; Cell Line, Tumor; Dacarbazine; DNA Repair; Drug Resistance, Neoplasm; Forkhead Box Protein M1; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Gene Silencing; Glioblastoma; Humans; Prognosis; Promoter Regions, Genetic; Protein Binding; Rad51 Recombinase; Recurrence; Temozolomide; Transcription, Genetic; Transcriptional Activation	2012
Temozolomide for relapsed primary CNS lymphoma. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2012, Volume: 22, Issue:9 Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Dacarbazine; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Recurrence; Salvage Therapy; Temozolomide; Treatment Outcome	2012
A review of dose-dense temozolomide alone and in combination with bevacizumab in patients with first relapse of glioblastoma. Anticancer research, 2012, Volume: 32, Issue:9 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Clinical Trials as Topic; Dacarbazine; Dose-Response Relationship, Drug; Glioblastoma; Humans; Recurrence; Temozolomide	2012
Relapse of herpes encephalitis induced by temozolomide-based chemoradiation in a patient with malignant glioma. Journal of neurosurgery, 2013, Volume: 118, Issue:2 Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Dacarbazine; Encephalitis, Herpes Simplex; Glioma; Humans; Magnetic Resonance Imaging; Male; Recurrence; Temozolomide; Virus Activation	2013
ABVD alone and a PET scan complete remission negates the need for radiologic surveillance in early-stage, nonbulky Hodgkin lymphoma. Cancer, 2013, Mar-15, Volume: 119, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiation Monitoring; Radiography; Recurrence; Remission Induction; Treatment Outcome; Vinblastine; Young Adult	2013
Involved node radiation therapy: an effective alternative in early-stage hodgkin lymphoma. International journal of radiation oncology, biology, physics, 2013, Mar-15, Volume: 85, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Heart Diseases; Hodgkin Disease; Humans; Lymphatic Irradiation; Male; Middle Aged; Neoplasm Staging; Radiation Injuries; Radiotherapy Dosage; Recurrence; Retrospective Studies; Treatment Outcome; Vinblastine; Young Adult	2013
Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boost. Radiation oncology (London, England), 2013, Jan-02, Volume: 8 Topics: Brain Neoplasms; Contrast Media; Dacarbazine; Glioblastoma; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Spectroscopy; Middle Aged; Radiometry; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Recurrence; Temozolomide; Tomography, X-Ray Computed	2013
Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experience. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2013, Volume: 29, Issue:4 Topics: Adolescent; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Camptothecin; Child; Child, Preschool; Dacarbazine; Drug Administration Schedule; Female; Humans; Infant; Irinotecan; Male; Medulloblastoma; Recurrence; Retrospective Studies; Temozolomide; Treatment Outcome	2013
Treatment of leptomeningeal relapse of medulloblastoma with temozolomide. Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:7 Topics: Brain; Child; Dacarbazine; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Recurrence; Temozolomide	2002
[Relapse of Hodgkin disease after 17 years of complete remission. A case report]. Revista medica de Chile, 2003, Volume: 131, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Fatal Outcome; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Recurrence; Remission Induction; Time Factors; Treatment Failure; Vinblastine; Vincristine	2003
Recurrent bilateral spontaneous pneumothorax complicating chemotherapy for metastatic sarcoma. Southern medical journal, 2003, Volume: 96, Issue:8 Topics: Acute Disease; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chest Tubes; Dacarbazine; Doxorubicin; Dyspnea; Female; Humans; Lung Neoplasms; Middle Aged; Pleurodesis; Pneumothorax; Recurrence; Sarcoma; Thoracic Surgery, Video-Assisted; Thoracostomy; Tibia; Tomography, X-Ray Computed; Treatment Outcome	2003
Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy. International journal of radiation oncology, biology, physics, 2003, Dec-01, Volume: 57, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lung Neoplasms; Male; Mechlorethamine; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy; Recurrence; Retrospective Studies; Survival Analysis; Thoracic Wall; Vinblastine; Vincristine	2003
[Asplenia in the Hodgkin's patient]. Presse medicale (Paris, France : 1983), 2003, Sep-06, Volume: 32, Issue:28 Suppl Topics: Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Follow-Up Studies; Hodgkin Disease; Humans; Immunosuppression Therapy; Prognosis; Radiotherapy; Radiotherapy Dosage; Recurrence; Risk Factors; Spleen; Splenectomy; Time Factors; Transplantation, Autologous; Vinblastine	2003
Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma. International journal of radiation oncology, biology, physics, 2004, Jul-01, Volume: 59, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Recurrence; Remission Induction; Treatment Outcome; Vinblastine; Vincristine	2004
Prospective study of combined modality treatment or radiotherapy alone in the management of early-stage adult Hodgkin's disease. International journal of radiation oncology, biology, physics, 2004, Nov-01, Volume: 60, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Prospective Studies; Recurrence; Regression Analysis; Salvage Therapy; Survival Rate; Vinblastine	2004
Significance of splenomegaly in childhood Hodgkin disease. Journal of pediatric hematology/oncology, 2004, Volume: 26, Issue:12 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Prednisone; Procarbazine; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Splenomegaly; Treatment Outcome; Vinblastine; Vincristine	2004
Mid- and post-ABVD gallium scanning predicts for recurrence in early-stage Hodgkin's disease. International journal of radiation oncology, biology, physics, 2005, Jan-01, Volume: 61, Issue:1 Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Child; Dacarbazine; Doxorubicin; Female; Gallium Radioisotopes; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Recurrence; Treatment Outcome; Vinblastine	2005
[Influence of age on treatment results in children and adolescents with Hodgkin's disease]. Przeglad lekarski, 2004, Volume: 61 Suppl 2 Topics: Adolescent; Age Distribution; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Child, Preschool; Dacarbazine; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Radiation; Doxorubicin; Female; Hodgkin Disease; Humans; Logistic Models; Male; Multicenter Studies as Topic; Poland; Prednisone; Radiotherapy Dosage; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Survival Analysis; Time Factors; Vincristine	2004
[Over 30-year experience of Polish Pediatric Leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications]. Przeglad lekarski, 2004, Volume: 61 Suppl 2 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Multicenter Studies as Topic; Poland; Prednisolone; Prednisone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Retrospective Studies; Survival Analysis; Time Factors; Vinblastine; Vincristine	2004
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin's disease. Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Diagnosis, Differential; Doxorubicin; Hodgkin Disease; Humans; Incidence; Neoplasm Staging; Recurrence; Risk Assessment; Vinblastine	2005
Economic evaluation of temozolomide in the treatment of recurrent glioblastoma multiforme. PharmacoEconomics, 2005, Volume: 23, Issue:8 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cost-Benefit Analysis; Dacarbazine; Finland; Glioblastoma; Humans; Recurrence; Temozolomide	2005
Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure. International journal of radiation oncology, biology, physics, 2005, Dec-01, Volume: 63, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prognosis; Recurrence; Salvage Therapy; Sex Factors; Treatment Failure; Vinblastine; Vincristine	2005
Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Sep-01, Volume: 23, Issue:25 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Infant; Male; Recurrence; Retrospective Studies; Salvage Therapy; Vinblastine	2005
Salvage temozolomide for prior temozolomide responders. Cancer, 2005, Dec-01, Volume: 104, Issue:11 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Dacarbazine; Female; Glioblastoma; Humans; Male; Middle Aged; Oligodendroglioma; Recurrence; Retrospective Studies; Salvage Therapy; Survival Analysis; Temozolomide	2005
Therapies for relapsed Hodgkin lymphoma: transplant and non-transplant approaches including immunotherapy. Hematology. American Society of Hematology. Education Program, 2005 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Incidence; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy; Recurrence; Stem Cell Transplantation; Vinblastine; Vincristine	2005
Benign pleural schwannoma secondary to radiotherapy for Hodgkin disease. American journal of clinical oncology, 2005, Volume: 28, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Basal Cell; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Goiter, Nodular; Hodgkin Disease; Humans; Mechlorethamine; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neurilemmoma; Pleural Neoplasms; Prednisone; Procarbazine; Radiotherapy; Recurrence; Skin Neoplasms; Vinblastine; Vincristine	2005
[Lymph node tuberculosis as primary manifestation of Hodgkin's disease]. Medizinische Klinik (Munich, Germany : 1983), 2006, Jun-15, Volume: 101, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Biopsy; Bleomycin; Dacarbazine; Diagnosis, Differential; Disease Progression; Doxorubicin; Hodgkin Disease; Humans; Lymph Nodes; Recurrence; Tomography, X-Ray Computed; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Vinblastine	2006
[Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2006, Volume: 28, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Leukopenia; Lymphatic Irradiation; Lymphatic Metastasis; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Recurrence; Retrospective Studies; Survival Rate; Vinblastine; Vincristine	2006
High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only. Leukemia & lymphoma, 2006, Volume: 47, Issue:8 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, B-Cell; Male; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Vinblastine	2006
[Limphomatous meningitis as recurrence site in Hodgkin's disease]. Medicina, 2006, Volume: 66, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Diagnosis, Differential; Doxorubicin; Etoposide; Fatal Outcome; Hodgkin Disease; Humans; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Paraneoplastic Syndromes; Prednisone; Procarbazine; Recurrence; Vinblastine; Vincristine	2006
Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2006, Volume: 12, Issue:10 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Child; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisone; Procarbazine; Prospective Studies; Recurrence; Risk; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Tumor Burden; Vinblastine; Vincristine	2006
Current role and future developments of radiotherapy in early-stage favourable Hodgkin's lymphoma. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2007, Volume: 183 Spec No 2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Follow-Up Studies; Forecasting; Hodgkin Disease; Humans; Lymph Nodes; Neoplasm Staging; Prospective Studies; Quality Assurance, Health Care; Radiotherapy; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Survival Analysis; Time Factors; Treatment Failure; Treatment Outcome; Vinblastine	2007
Pilot studies using melanoma tumor-associated antigens (TAA) in specific-active immunochemotherapy of malignant melanoma. Cancer, 1982, Apr-01, Volume: 49, Issue:7 Topics: Adult; Aged; Antigens, Neoplasm; Chromatography, Affinity; Dacarbazine; Drug Administration Schedule; Female; Humans; Immunity, Cellular; Immunization; Male; Melanoma; Middle Aged; Neoplasm Staging; Pilot Projects; Prognosis; Random Allocation; Recurrence; Skin Neoplasms	1982
Continuous infusion ABDIC therapy for relapsed or refractory Hodgkin's disease. Cancer, 1994, Feb-15, Volume: 73, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Infusions, Intravenous; Lomustine; Male; Middle Aged; Prednisone; Recurrence; Salvage Therapy; Survival Analysis	1994
Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease. Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Pancytopenia; Prednisone; Procarbazine; Prospective Studies; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Vinblastine; Vincristine	1994
[A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1994, Volume: 170, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Germany, West; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy Dosage; Recurrence; Retrospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine	1994
Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy. Cancer, 1993, Jul-01, Volume: 72, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Vinblastine; Vincristine	1993
Pediatric stage IV Hodgkin disease. Long-term survival. Cancer, 1993, Jul-01, Volume: 72, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Doxorubicin; Follow-Up Studies; Hodgkin Disease; Humans; Lung Neoplasms; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Recurrence; Remission Induction; Retrospective Studies; Survival Rate; Vinblastine; Vincristine	1993
Late relapses in Hodgkin's disease: outcome of patients relapsing more than twelve months after primary chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prognosis; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Time Factors; Vinblastine; Vincristine	1993
Genetic instability in patients with Hodgkin's disease undergoing chemotherapy. The Journal of clinical investigation, 1995, Volume: 96, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Gene Rearrangement, T-Lymphocyte; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Recurrence; Time Factors; Vinblastine; Vincristine	1995
Detection of a dormant 20q- leukemia clone in bone marrow cultures with hematopoietic growth factors: implications for secondary leukemia post-transplant. Bone marrow transplantation, 1997, Volume: 19, Issue:5 Topics: Acute Disease; Adult; Anemia, Refractory, with Excess of Blasts; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Bone Marrow Transplantation; Chromosome Deletion; Chromosomes, Human, Pair 20; Clone Cells; Combined Modality Therapy; Cytarabine; Dacarbazine; Doxorubicin; Female; Hematopoietic Cell Growth Factors; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm, Residual; Neoplasms, Second Primary; Neoplastic Stem Cells; Prednisone; Procarbazine; Radiotherapy; Recurrence; Transplantation, Autologous; Vinblastine; Vincristine	1997
Safety and efficacy of isolated perfusion of extremities for recurrent tumor in elderly patients. Surgery, 1998, Volume: 123, Issue:3 Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Dacarbazine; Edema; Extremities; Female; Humans; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Perfusion; Recurrence; Skin Neoplasms	1998
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications. British journal of cancer, 1998, Volume: 77, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Combined Modality Therapy; Confidence Intervals; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lymph Nodes; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Receptors, Interleukin-2; Recurrence; Reference Values; Retrospective Studies; Vinblastine; Vincristine	1998
Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research, 1995, Volume: 1, Issue:2 Topics: Adult; Aged; alpha 1-Antitrypsin; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blast Crisis; Bleomycin; Bone Marrow; Cyclophosphamide; Dacarbazine; Danazol; Disease-Free Survival; Doxorubicin; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nimustine; Peptide Fragments; Prednisone; Probability; Procarbazine; Prognosis; Proteinuria; Recurrence; Remission Induction; Reproducibility of Results; Tamoxifen; Time Factors; Vincristine	1995
[High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer]. Harefuah, 2000, Volume: 139, Issue:5-6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cytarabine; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Mechlorethamine; Melphalan; Middle Aged; Podophyllotoxin; Prednisone; Procarbazine; Recurrence; Retrospective Studies; Survival Rate; Time Factors; Vinblastine; Vincristine	2000
Repeatable acute rhabdomyolysis with multiple organ dysfunction because of interferon alpha and dacarbazine treatment in metastatic melanoma. The British journal of dermatology, 2001, Volume: 144, Issue:1 Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Humans; Interferon alpha-2; Interferon-alpha; Male; Melanoma; Multiple Organ Failure; Recombinant Proteins; Recurrence; Rhabdomyolysis	2001
Persistent paraneoplastic neurologic syndrome after successful therapy of Hodgkin's disease. European journal of haematology, 2001, Volume: 66, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Guillain-Barre Syndrome; Hodgkin Disease; Humans; Mechlorethamine; Middle Aged; Muscle Hypotonia; Paraneoplastic Syndromes; Peripheral Nervous System Diseases; Polyneuropathies; Prednisone; Pregnancy; Procarbazine; Puerperal Disorders; Purpura, Thrombocytopenic, Idiopathic; Recurrence; Reflex, Abnormal; Sensation Disorders; Vinblastine; Vincristine	2001
Radiation recall dermatitis in a patient treated with dacarbazine. Clinical oncology (Royal College of Radiologists (Great Britain)), 2001, Volume: 13, Issue:6 Topics: Administration, Oral; Adult; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Glucocorticoids; Humans; Melanoma; Prednisolone; Radiodermatitis; Recurrence; Skin Neoplasms	2001
Failure of lymphocyte microcytotoxicity to distinguish relapsers from non-relapsers in melanoma patients receiving post-surgical adjuvant chemotherapy. European journal of cancer, 1978, Volume: 14, Issue:7 Topics: Adult; Cytotoxicity, Immunologic; Dacarbazine; Female; Humans; Lymphocytes; Male; Melanoma; Middle Aged; Prognosis; Recurrence	1978
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission. Annals of oncology : official journal of the European Society for Medical Oncology, 1990, Volume: 1, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednimustine; Prednisone; Procarbazine; Recurrence; Vinblastine; Vincristine	1990